Story perspectives
Study Reveals GLP-1 Drugs May Mislead Cancer Diagnoses
10/11/2025
50 5
1 of 1
Story summary
- A study at the European Association of Nuclear Medicine (EANM 2025) warns GLP-1 receptor agonists, including Ozempic and Wegovy, may cause false cancer diagnoses on PET-CT.
- Researchers found unusual tracer patterns in patients using these medications that resemble cancer.
- Australia has scan-preparation recommendations.
- The United Kingdom currently lacks guidance.
- Further research is planned to establish international protocols.
